Summary Following my coverage of Zillow Group (NASDAQ:ZG) in May’24, for which I recommended a buy rating due to the various visible growth catalysts...
BridgeBio Pharma Inc. (NASDAQ:BBIO) is a biopharmaceutical company that focuses on developing innovative therapies for genetic diseases. The company’s research and development platform uses...